Co-expression of Flt-3 ligand gene ablates tumor immunity elicited by HER-2/neu DNA vaccine in transgenic mice

被引:1
|
作者
Venanzi, F. M. [1 ]
Barucca, A. [1 ,2 ]
Havas, K. [1 ]
Capitani, M. [1 ]
Provinciali, M. [2 ]
Scotti, S. [2 ]
Concetti, A. [1 ]
机构
[1] Univ Camerino MC, Lab Translat Biol, Dept Biol MCA, Camerino, Italy
[2] INRCA Ancona, Lab Tumor Immunol, Sci Technol Area, Ancona, Italy
关键词
Breast cancer; Anti-HER-2; antibody; HER-2 DNA vaccination; Flt-3 ligand gene; TYROSINE KINASE RECEPTOR; DENDRITIC CELLS; IN-VIVO; BREAST-CANCER; LUNG-CANCER; RESPONSES; ANTIGEN; GENERATION; ADJUVANT; ANTIBODY;
D O I
10.1016/j.vaccine.2010.03.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fms-like tyrosine-kinase 3 ligand (Flt-3L), is a powerful hematopoyetic growth factor, known to modulate the immune response against delivered antigens by acting either as an adjuvant or tolerogenic stimulus. In this study we evaluated the use of murine Flt-3 ligand plasmid (pFI) in combination with a DNA vaccine encoding rat-p185 oncoprotein extra cellular domain (pECD) in the prevention of mammary carcinogenesis in rat-neu HER-2 mutated (neuT) transgenic mice. We demonstrate that intramuscular (i.m.) co-immunization of pFI inhibits the production of anti-HER-2 antibody elicited by pECD vaccine, resulting in the development of spontaneous carcinomas in all co-immunized mice. The inhibitory effect on antibody production by mFlt3 gene appeared to be: dose-dependent, linked to the injection site and timing, and transient in nature. Additionally, we show that co-administration of pFI and pECD plasmids was unable to trigger cytotoxic T-cell immune response in neuT mice. On the other hand, we found that the combination of pFI with pECD had no impact on the ability of pECD to reject HER-2+ transplantable tumors in parental mice. In summary our results demonstrate that, depending on tumor model, co-administration of pFI gene can produce untoward effects to immune response, and thus its application as a vaccine adjuvant should be carefully evaluated. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3841 / 3847
页数:7
相关论文
共 31 条
  • [21] Immunization with a multiepitope peptide vaccine and co-administration of IL-12 prevents tumor growth in Her-2 transgenic mice
    Wagner, S
    Jasinska, J
    Breiteneder, H
    Pehamberger, H
    Scheiner, O
    Zielinski, CC
    Wiedermann, U
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S243 - S244
  • [22] Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine
    Yo, Y-T
    Hsu, K-F
    Shieh, G-S
    Lo, C-W
    Chang, C-C
    Wu, C-L
    Shiau, A-L
    CANCER GENE THERAPY, 2007, 14 (11) : 904 - 917
  • [23] Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine
    Y-T Yo
    K-F Hsu
    G-S Shieh
    C-W Lo
    C-C Chang
    C-L Wu
    A-L Shiau
    Cancer Gene Therapy, 2007, 14 : 904 - 917
  • [24] Insertion of the DNA for the 163–171 peptide of IL1β enables a DNA vaccine encoding p185neu to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice
    S Rovero
    K Boggio
    E Di Carlo
    A Amici
    E Quaglino
    P Porcedda
    P Musiani
    G Forni
    Gene Therapy, 2001, 8 : 447 - 452
  • [25] Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity
    Spadaro, M
    Ambrosino, E
    Iezzi, M
    Di Carlo, E
    Sacchetti, P
    Curcio, C
    Amici, A
    Wei, WZ
    Musiani, P
    Lollini, PL
    Cavallo, L
    Forni, G
    CLINICAL CANCER RESEARCH, 2005, 11 (05) : 1941 - 1952
  • [26] Cancer fatty acid metabolism regulates Her-2/neu (erbB-2) oncogene expression via formation of "PEA3 transcription factor-PEA3 DNA binding site" complexes on the Her-2/neu gene promoter
    Menendez, Javier A., Sr.
    Papadimitropoulou, Adriana
    Vellon, Luciano
    Lupu, Ruth
    CANCER RESEARCH, 2006, 66 (08)
  • [27] HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
    Vertuani, Simona
    Triulzi, Chiara
    Roos, Anna Karin
    Charo, Jehad
    Norell, Hakan
    Lemonnier, Francois
    Pisa, Pavel
    Seliger, Barbara
    Kiessling, Rolf
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (05) : 653 - 664
  • [28] HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
    Simona Vertuani
    Chiara Triulzi
    Anna Karin Roos
    Jehad Charo
    Håkan Norell
    François Lemonnier
    Pavel Pisa
    Barbara Seliger
    Rolf Kiessling
    Cancer Immunology, Immunotherapy, 2009, 58 : 653 - 664
  • [29] Co-expression of interleukin-2 to increase the efficacy of DNA vaccine-mediated protection in coxsackievirus B3-infected mice
    Henke, A
    Chiang, CS
    Zell, R
    Stelzner, A
    ANTIVIRAL RESEARCH, 2004, 64 (02) : 131 - 136
  • [30] Regression of established autochthonous mammary tumors and induction of systemic anti-tumor T- and B-cell immunity in HER-2/NEU transgenic mice after treatment with IL-12 and GM-CSF-encapsulated microspheres
    Nair, ER
    Jong, YS
    Egilmez, NK
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S37 - S37